Neogen Chemicals Q1 Results: Net profit rises 36% YoY to ₹19.44 crore
Neogen Chemicals posted a 36.6% YoY rise in Q1FY26 net profit to ₹19.44 crore, with revenue jumping 36.7% to ₹252.28 crore. The Board approved a ₹600 crore fund raise and set August 13 as the dividend record date.

*this image is generated using AI for illustrative purposes only.
Neogen Chemicals Limited reported a standalone net profit of ₹19.44 crore for the quarter ended June 30, 2026, marking a 36.6% year-on-year increase from ₹14.23 crore in Q1FY25. Revenue from operations rose 36.7% to ₹252.28 crore, up from ₹184.58 crore in the corresponding prior period, reflecting strong operational recovery following the March 2025 fire incident at its Dahej SEZ plant. Consolidated net profit grew 67.0% to ₹17.11 crore, while consolidated revenue increased 34.1% to ₹250.29 crore.
The Board of Directors, meeting on July 24, 2026, approved the unaudited financial results reviewed by statutory auditors Chandabhoy & Jassoobhoy. Management also granted in-principle approval to raise funds of up to ₹600 crore through equity shares, qualified institutional placements (QIP), or other eligible securities, subject to shareholder and regulatory approvals. Additionally, the Board appointed CNK & Associates as the internal auditor for FY2026-27 and scheduled the 37th Annual General Meeting for August 21, 2026.
Financial Performance
Standalone operating margins expanded to 19.09% from 17.68% in FY25, while net profit margins improved to 7.70% from 5.49%. Finance costs rose to ₹23.10 crore from ₹14.03 crore year-on-year, partly offset by higher revenue growth. Consolidated EBITDA margins stood at 19.35%, compared to 15.96% in FY25. The company’s debt-equity ratio improved to 0.68 times from 0.79 times at the end of FY25, indicating a strengthening balance sheet.
| Metric | Q1FY26 (₹ Cr) | Q1FY25 (₹ Cr) | Change |
|---|---|---|---|
| Revenue from Operations | 252.28 | 184.58 | +36.7% |
| Net Profit (Standalone) | 19.44 | 14.23 | +36.6% |
| Net Profit (Consolidated) | 17.11 | 10.26 | +67.0% |
| Operating Margin (%) | 19.09% | 17.68% | +141 bps |
Insurance Claim Recovery
The company continues to recover from the fire incident on March 5, 2025, which caused a recognized loss of ₹348.16 crore. As of June 30, 2026, Neogen Chemicals had received ₹140.00 crore as on-account payments and realized ₹9.38 crore from scrap sales. An additional ₹15.00 crore was received post-quarter-end, reducing the outstanding insurance claim receivable to ₹186.63 crore. Management maintains that the remaining claim is fully recoverable.
Capital Raise and Shareholder Updates
The Board’s in-principle approval for a ₹600 crore fund raise allows flexibility in instrument choice, including equity and debt, to support future growth initiatives. The record date for determining eligibility for remote e-voting and the final dividend for FY25 is set for August 13, 2026. The Register of Members will remain closed from August 14, 2026, to August 21, 2026. Crisil Ratings Limited downgraded the company’s long-term rating to 'Crisil A-/Negative' from 'Crisil A/Negative' on July 17, 2026, leading to a coupon rate increase on its ₹200 crore NCDs from 10.50% to 11.00% per annum.
Historical Stock Returns for Neogen Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.06% | -5.13% | +6.18% | +85.37% | +28.73% | +125.94% |
How will the ₹600 crore capital raise be allocated between debt reduction and growth initiatives, and what impact will this have on the company's leverage ratio?
What specific operational strategies is Neogen Chemicals implementing to sustain the expanded operating margins of 19.09% amid potential raw material price volatility?
Given the Crisil rating downgrade and the 50 bps increase in NCD coupon rates, how might this affect the company's cost of capital for future borrowing?
































